Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07889648) titled 'A Clinical Study to Evaluate the Effects of Enicepatide Versus Tirzepatide in Participants With Type 2 Diabetes and Inadequate Blood Sugar Control on Oral Glucose-Lowering Medications' on Oct. 16.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Hoffmann-La Roche
Condition:
Type 2 Diabetes Mellitus
Intervention:
Combination Product: Enicepatide
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: December 1, 2026
Target Sample Size: 948
To know more, vi...